Table 2 Ruptured nephroblastoma
NO. | Author | Year | Patient age (mean) | Number of patients | Sex (M:F) | Tumor size | Location (L:R) | Treatment options | Clinical manifestations and complications | Type of pathology |
|---|---|---|---|---|---|---|---|---|---|---|
1 | Marie-Amelyne Le Rouzic et al. [7] | 2019 | 4 years | 28 | 12:16 | ≤400 ml: 7 ≥400 ml: 20 | 12:16 | Preoperative chemotherapy + surgery + postoperative chemotherapy | Recurrence: 3 Death: 2 | Epithelial type: 1 Mixed type: 9 Regressive type: 12 Blastemal type: 5 Diffuse anaplastic type:1 |
2 | Zhang Y et al. [8] | 2020 | 42.5 ± 18.7 Months | 41 | 24: 17 | Average diameter:12 cm Volume:533.6 cm3 | 20:21 | Immediate group (immediate surgery without preoperative chemotherapy): 13 Delayed group (delayed surgery after preoperative chemotherapy): 28 | Immediate group: Partial rupture: 12 Continuous bleeding: 1 Recurrence and metastasis: 2 Delayed group: Inferior vena cava tumor embolism: 4 Recurrence and metastasis: 8 Death: 7 | Immediate group: Blastemal type: 5 Mixed type: 8 Delayed group: Blastemal type: 5 Mixed type: 10 Epithelial type: 1 Stromal type: 2 Regressive type: 3 completely necrotic: 2 fetal rhabdomyoma nephroblastoma: 1 non-typable: 4 |
3 | The present example | 2020 | 5 years and 1 month | 1 | 0:1 | 3.1 × 3.2 × 4.2 cm | 1:0 | chemotherapy + surgery + postoperative chemotherapy | – | Mixed type: 1 |